Clinical Trial

Effect of the Postoperative Trendelenburg Position on Chronic Subdural Hematoma Recurrence

Study acronym: POTHeR
Recruiting
View on ClinicalTrials.gov →
Summary
Objective: Determine the effect of the postoperative trendelenburg position on the recurrence of chronic subdural hematoma (CSH) in patients undergoing surgery. Materials and Methods: An open-label, randomized, controlled clinical trial was conducted in three hospitals in Medellín. Patients with CSH were enrolled and assigned to the trendelenburg position (30° leg elevation and 10° head tilt) or a flat bed for 24 hours postoperatively. CSH recurrence was measured at 3 months, along with functional outcome (modified Rankin scale), adverse events, and comfort (Likert scale).
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2025-03-27; most recent amendment 2025-04-16.
Status change: Enrolling by Invitation → Recruiting 2025-04-16
Status change: Active, Not Recruiting → Enrolling by Invitation 2025-04-14
Trial Details
NCT Number NCT06911736
Lead Sponsor Universidad de Antioquia
Conditions Chronic Subdural Hematoma, Trendelenburg, Recurrence, Mortality, Prognosis, Clinical Trials
Enrollment 254 participants
Start Date 2024-06-01
Primary Completion 2025-02-28 (estimated)
Study Completion 2027-04-30 (estimated)
Updated on ClinicalTrials.gov 2025-04-22